As pharmaceutical companies grow, they face critical choices: Where should you manufacture your product? How do you choose the right CDMO? What risks come with global supply chains?
In this episode of Life Science Solutions, host Chris Adkins sits down with Roger Lias, PhD a 35-year veteran of the biologics manufacturing industry, to dig into the realities of onshoring in pharma and the evolving CDMO landscape.
Roger walks through geopolitics and the BIOSECURE Act to the practical hurdles of talent shortages and infrastructure buildouts. Roger outlines what sponsor companies need to consider when choosing a domestic or international partner, from experience working in APAC.
Topics include:
- Why “onshoring” may be more political theater than operational shift
- The labor and infrastructure gap in U.S. biologics manufacturing
- How CDMO specialization is reshaping the global pharma supply chain
From navigating regulatory risks to building smart tech transfer plans, this episode gives growing pharma teams the tools to make better decisions.
📍 Recorded at Kymanox HQ in Research Triangle Park, North Carolina.
#Biomanufacturing #CDMO #Onshoring #LifeSciences #Biologics #PharmaManufacturing
What is Life Science Solutions?
Presented by Kymanox, Life Science Solutions is dedicated to accelerating understanding and advancing expertise in the life sciences industry. Focused on bringing industry insights to light, our podcast offers a platform where regulatory, scientific, and engineering experts share practical knowledge on overcoming the challenges of product development and commercialization. Episodes equip listeners with the latest on regulatory updates, market trends, cutting-edge technology, and more. Join us as we explore the journey of modern medicines, ensuring every product reaches its full potential in safety, quality, and accessibility.